News
Hosted on MSN14m
Why Eli Lilly Stock Topped the Market Today
It wasn't much of a surprise that investors cautiously bid up Eli Lilly stock -- and that of its GLP-1 drug making rival, Wegovy developer Novo Nordisk-- following the article's publication. Any such ...
President Donald Trump's new European tariffs could significantly increase the cost of Novo Nordisk's weight loss drug, Ozempic.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results